Cephalon To Buy ChemGenex Pharmac For A$225 Mln In Cash
Cephalon To Buy ChemGenex Pharmac For A$225 Mln In Cashuser: admin
ChemGenex - a stock that has been up & down - their sceince explaineduser: Jason
Hospira deal with Australian Chemgenex - who is Hospira?user: Jason
ABC Catalyst - Prostate Cancer Diagnosisuser: Jason
Robotic prostate surgery may mean better sex life.user: admin
Browse next 5 videos of 7
About the Video
Cephalon Inc. (NASDAQ:CEPH) agreed to buy Australian ChemGenex Pharmaceuticals
Terms & Rules
As per ASIC Regulatory Guide 162: All investment tips and comments appearing on this website (Poll results, BLOGS & discussion forums) are submitted by the general public who are not licensed financial advisors. None of the information on this website is financial or investment advice, you should seek independent financial or investment advice by a licensed financial or investment advisor before entering into any position of financial risk. Before using this website, you must agree to the BioInvesting.com.au Terms Of Use